Labat AfricaJSE:LAB +25.00% EV-to-EBITDA is 1.18 as of Jul. 07, 2026. The stock has 5 warning signs investors should review. Among 741 Drug Manufacturers companies, Labat Africa ranks better than 96.09% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Labat Africa's enterprise value is R255.6 Mil.
Labat Africa's EBITDA for the trailing twelve months (TTM) ended in Nov. 2025 was R215.8 Mil. Therefore, Labat Africa's EV-to-EBITDA for today is 1.18.
The historical rank and industry rank for Labat Africa's EV-to-EBITDA or its related term are showing as below:
JSE:LAB'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -32.34 Med: -0.92 Max: 317.25
Current: 1.19
During the past 13 years, the highest EV-to-EBITDA of Labat Africa was 317.25. The lowest was -32.34. And the median was -0.92.
JSE:LAB's EV-to-EBITDA is ranked better than 96.09% of 741
companies
in the Drug Manufacturers industry
Industry Median: 12.86
vs JSE:LAB: 1.19
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
Labat Africa (JSE:LAB) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Labat Africa's PE Ratio (TTM) for today is calculated as:
Labat Africa's share price for today is R0.05.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Labat Africa's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Nov. 2025 was R0.134.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Labat Africa's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JSE:LAB vs ZTS, UTHR, VTRS: EV-to-EBITDA Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Labat Africa's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Labat Africa EV-to-EBITDA vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Labat Africa's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Labat Africa's EV-to-EBITDA falls into.
Labat Africa's current Enterprise Value is R255.6 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Labat Africa's EBITDA for the trailing twelve months (TTM) ended in Nov. 2025 was R215.8 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Labat Africa (JSE:LAB) has a EV-to-EBITDA of 1.18 as of Jul. 07, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Labat Africa. According to the industry distribution chart, Labat Africa ranks #29 out of 741 companies in the Drug Manufacturers industry, placing it in the top 3.9%.
Is Labat Africa's EV-to-EBITDA too high?
Labat Africa's current EV-to-EBITDA is 1.18. The Drug Manufacturers industry median EV-to-EBITDA is 12.86. Labat Africa's value of 1.18 is 90.8% below this industry median. Based on the distribution chart, Labat Africa ranks #29 out of 741 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers.
How does Labat Africa's EV-to-EBITDA compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Labat Africa ranks #29 out of 741 companies for EV-to-EBITDA. This places Labat Africa in the top 4% of its industry — outperforming the majority of peers. The industry median EV-to-EBITDA is 12.86. Labat Africa's value of 1.18 is 90.8% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Drug Manufacturers company?
The median EV-to-EBITDA among Drug Manufacturers companies is 12.86, based on 741 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Labat Africa's current EV-to-EBITDA of 1.18 is 90.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Labat Africa. For the Drug Manufacturers industry, the median EV-to-EBITDA is 12.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Labat Africa's current EV-to-EBITDA is 1.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Labat Africa stock overvalued right now?
Based on GuruFocus' analysis, Labat Africa (JSE:LAB) is currently considered Possible Value Trap. The stock's GF Value™ is R0.18, compared to a current price of R0.05 — trading 72.2% below its estimated fair value. The current EV-to-EBITDA is 1.18 and 90.8% below the Drug Manufacturers industry median of 12.86. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Labat Africa (JSE:LAB), the current EV-to-EBITDA is 1.18 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Labat Africa Ltd is an investment holding company. Through its subsidiaries, the company operates in the following segments; Technology, Head office, and Healthcare. The Technology segment manufactures and distributes integrated circuits South African Micro - Electronic Systems. Head office operations provide management services, logistics and seeks further investment opportunities for the Group. The Healthcare segment generates maximum revenue for the company and focusses on medical cannabis industry in South Africa. Geographically, the company carries out its business operations in South Africa.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JSE:LAB has been successfully added to your 